We are live on ! Find out more

974 hedge funds and large institutions have $47.5B invested in DexCom in 2023 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 326 increasing their positions, 358 reducing their positions, and 114 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 114

47% more funds holding in top 10

Funds holding in top 10: 1725 (+8)

38% more capital invested

Capital invested by funds: $34.4B → $47.5B (+$13.2B)

8% more funds holding

Funds holding: 903974 (+71)

4.32% more ownership

Funds ownership: 94.93%99.24% (+4.3%)

9% less repeat investments, than reductions

Existing positions increased: 326 | Existing positions reduced: 358

22% less call options, than puts

Call options by funds: $824M | Put options by funds: $1.05B

Holders
974
Holders Change
+71
Holders Change %
+7.86%
% of All Funds
14.2%
Holding in Top 10
25
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+47.06%
% of All Funds
0.36%
New
195
Increased
326
Reduced
358
Closed
114
Calls
$824M
Puts
$1.05B
Net Calls
-$228M
Net Calls Change
-$149M
Name Holding Trade Value Shares
Change
Change in
Stake
Bessemer Group
51
Bessemer Group
New Jersey
$165M +$29.1M +285,136 +27%
Wells Fargo
52
Wells Fargo
California
$163M -$5.85M -57,265 -4%
Allspring Global Investments
53
Allspring Global Investments
North Carolina
$159M -$2.79M -27,345 -2%
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$157M +$85.3M +834,641 +194%
Swiss National Bank
55
Swiss National Bank
Switzerland
$151M -$3.47M -34,000 -3%
VNIM
56
Vaughan Nelson Investment Management
Texas
$145M -$30M -293,883 -20%
Tiger Global Management
57
Tiger Global Management
New York
$143M +$118M +1,152,806 New
Natixis Advisors
58
Natixis Advisors
Massachusetts
$140M +$67.6M +661,584 +141%
CAM
59
Congress Asset Management
Massachusetts
$140M +$110M +1,074,626 +2,076%
Barclays
60
Barclays
United Kingdom
$138M +$9.04M +88,500 +9%
DekaBank Deutsche Girozentrale
61
DekaBank Deutsche Girozentrale
Germany
$131M +$8.07M +78,959 +8%
Ensign Peak Advisors
62
Ensign Peak Advisors
Utah
$129M +$36.9M +361,530 +53%
Victory Capital Management
63
Victory Capital Management
Texas
$128M -$484K -4,737 -0.5%
UBS Group
64
UBS Group
Switzerland
$128M -$4.61M -45,110 -4%
Millennium Management
65
Millennium Management
New York
$127M -$179M -1,754,429 -63%
FAM
66
Fred Alger Management
New York
$126M +$23.2M +227,090 +29%
Sumitomo Mitsui Trust Group
67
Sumitomo Mitsui Trust Group
Japan
$125M -$1.8M -17,661 -2%
BAMCO Inc
68
BAMCO Inc
New York
$124M -$32.8M -321,358 -24%
Fisher Asset Management
69
Fisher Asset Management
Washington
$123M -$2.15M -21,077 -2%
Baird Financial Group
70
Baird Financial Group
Wisconsin
$123M +$7.99M +78,239 +9%
EPFB
71
Employees Provident Fund Board
Malaysia
$122M +$6.97M +68,207 +7%
HSBC Holdings
72
HSBC Holdings
United Kingdom
$117M +$2.13M +20,889 +2%
BG
73
Bellevue Group
Switzerland
$113M +$23.4M +228,860 +33%
National Pension Service
74
National Pension Service
South Korea
$108M +$2.34M +22,931 +3%
Citigroup
75
Citigroup
New York
$108M +$41.3M +404,266 +86%

DXCM Hedge Fund Activity: Q4 2023 in Review

974 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2023, worth a combined $47.5B — up 38% from $34.4B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new DXCM positions and 114 closed out — a net gain of 81 holders — while 326 added to existing stakes and 358 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $590M. The largest seller was Jennison Associates, cutting an estimated $400M.

  • 974 institutional investors held DexCom (DXCM) as of Q4 2023, up from 903 in Q3 2023.
  • Funds reported $47.5B of DexCom stock for Q4 2023, up 38% quarter-over-quarter.
  • 195 funds opened new DexCom positions in Q4 2023 and 114 closed out, a net change of +81 holders.
  • The largest DexCom buyer in Q4 2023 was Morgan Stanley, an estimated $590M added.
  • The largest DexCom seller in Q4 2023 was Jennison Associates, an estimated $400M sold.

Based on aggregated 13F filings for Q4 2023.